|
Note: This index does not cover the CAP TODAY “Marketplace” or “Abstracts” columns.
AACC meetings
Pulling back the reins on superfluous testing, 09/10:1
In coagulation, reflexive testing algorithms do the trick, 09/10:52
AACC 2010 Annual Meeting vendor exhibit coverage, 09/10:108
AIDS/HIV/other blood borne diseases
Fourth-gen tests closing window on HIV detection, 08/10:40
American Board of Pathology
Meeting MOC requirements: ABP answers questions, 05/10:44
From the ABP, more MOC questions and answers, 10/10:82
Analyzer surveys (see Instrumentation/instrument surveys)
Antibiotic resistance
New AST breakpoints bolster fight against resistance, 09/10:58
Another resistance mechanism poses worldwide threat, 09/10:66
APIII meeting
Not so fast? Concrete considerations for digital move, 01/10:56
Armed Forces Institute of Pathology
New center underway as AFIP winds down, 10/10:64
Automation
Lab automation—open, modular, informatics-focused, 09/10:18
Billing/revenue cycle management
Ratcheting up labs’ revenue cycle management, 05/10:18
With billing systems, the proof’s in the pay, 05/10:18
Biomarkers
Solid (tumor) reasons for molecular biomarkers, 02/10:60
Blood/coagulation/hematology (see also Blood banking/transfusion)
For WBC differentials, report in absolute numbers, 03/10:12
Room to grow—warfarin self-testing still lags, 08/10:60
Blueprint for blue-penciling phlebotomy errors, 09/10:1
In coagulation, reflexive testing algorithms do the trick, 09/10:52
Scuttling surrogate testing of platelets, 11/10:1
To and fro on band count reporting and clinical utility, 11/10:54
Blood banking/transfusion
Closing the gap in transfusion-related iron overload, 05/10:1
In cardiac surgery, there will be blood—but why? 12/10:58
C. difficile testing
C. diff molecular testing with less time and effort, 11/10:97
Cancer
Solid (tumor) reasons for molecular biomarkers, 02/10:60
Micrometastases still a waiting game, 03/10:1
Micrometastases turn answers to questions, 05/10:1
Pathologists picking up the pace in NSCLC, 06/10:1
New test could mean jump on lung cancer, 08/10:1
HPV testing—proceed, with cautions, 10/10:1
CAP ’09 meeting/CAP ’10 meeting
Common lab tests, uncommon problems, 01/10:1
28 winners—for service as leaders, teachers, speakers, and more, 10/10:78
Shape up? Ship out? Handling problem colleagues, 11/10:106
Trail of clues leads to infectious organisms, 12/10:1
CAP news
Personal learning about personalized medicine, 10/10:1
CAP programs/products/services (see also Q-Probes and test management)
See rare and unusual cases, and earn CME online, 01/10:52
Anatomic pathology programs—changes for 2010, 01/10:53
For CAP HPV Survey, choose your media type, 01/10:54
For WBC differentials, report in absolute numbers, 03/10:12
Making ER/PgR practices toe the line, 04/10:1
For CAP’s cancer protocols, a user-friendly format, 05/10:5
Unmasking specimen ID errors, every step of the way, 06/10:94
Checklists: flexing to meet a new decade’s demands, 06/10:109
Packing POC dossier into new online tool kit, 08/10:5
Accuracy-based Surveys carve higher QA profile, 10/10:42
CAP publications
Atlas blazes color path across full spectrum of urinalysis, 11/10:5
Cardiovascular disease/cardiac markers
Keeping in step with the perfecting of troponin, 01/10:1
GRAVITAS findings part of Plavix puzzle, 12/10:1
In cardiac surgery, there will be blood—but why? 12/10:58
Centers for Medicare & Medicaid Services
Sizing up the 2010 physician fee schedule final rule, 02/10:43
Charitable donations/endowed chairs
Sitting pretty—the power of endowed chairs, 03/10:68
Chemistry testing
Cholesterol—rethinking set practices, 03/10:50
Cholesterol
Cholesterol—rethinking set practices, 03/10:50
CLSI (formerly NCCLS)
New AST breakpoints bolster fight against resistance, 09/10:58
Core laboratories
For core laboratories, it’s all in the family, 07/10:1
Critical values/critical results
Critical value repeats—redundancy, necessity? 12/10:1
Cystic fibrosis
3 of a kind: CF screening, 03/10:1
Cytopathology and More
New FDA approvals of HPV vaccines, 01/10:48
What to do with contaminated cytospin machine, 01/10:48
Guidelines for reporting nongyn cytology specimens, 01/10:48
See rare and unusual cases, and earn CME online, 01/10:52
Anatomic pathology programs—changes for 2010, 01/10:53
For CAP HPV Survey, choose your media type, 01/10:54
Discovering best practices in gyn cytopathology, 01/10:54
Complying with cross-contamination question, 05/10:62
Q & A: EBC versus ECC, 05/10:62
Views from on top: A look at the Future of Cytopathology Summit, 05/10:62
Q & A: Clarifying ‘test performed’, 05/10:66
ACOG bulletin on cervical cytology screening, 05/10:68
Your questions about feedback, faxback, staining, and more, 05/10:70
Soon, a survey of gyn cytopathology practices, 05/10:73
Two new checklist questions, changes to others, 08/10:50
Licensure—status in the states and scope of practice, 08/10:54
Benchmarking data for laboratory use in QA, 08/10:56
Survey of gynecologic cytopathology practices set to begin, 08/10:58
Cytopathology/histology (see also Cytopathology and More)
Cytology screening limits, by the numbers, 10/10:1
Diabetes
Cola, confection, and confusion: OGTT alternatives for gestational diabetes, 6/10:78
A1c: added oomph to diagnosing diabetes, 7/10:1
Diagnostic assays/tests/test kits
New test could mean jump on lung cancer, 08/10:1
Fourth-gen tests closing window on HIV detection, 08/10:40
DICOM
All aboard—new DICOM standard for digital images, 09/10:94
Digital pathology/digital imaging/computer-assisted imaging
Not so fast? Concrete considerations for digital move, 1/10:56
All aboard—new DICOM standard for digital images, 09/10:94
Drug dosing
Honing drug dosing with standardized eGFR, 3/10:1
Editorials of CAP president (see From the President’s Desk)
Electronic health/medical records
Sailing safely through EMR software donations, 7/10:58
Electronic publishing
CAP TODAY readers turn page on digital issue, 7/10:89
Estimated glomerular filtration rate (eGFR)
Honing drug dosing with standardized eGFR, 3/10:1
Estrogen receptors/progesterone receptor
Making ER/PgR practices toe the line, 4/10:1
Executive War College
Sailing safely through EMR software donations, 7/10:58
Ins and outs, plus doubts, about TC/PC setups, 08/10:74
Social media in labs—hook, line, and sinker, 10/10:1
Fine-needle aspirations
When pathologists meet patients—lessons from one FNA practice, 12/10:64
Firsthand Views
Same people, better results, 1/10:86
The department as family. Really? 2/10:98
Parkinson’s Law, in reverse, 3/10:94
Where to meet optimists, 4/10:102
Servant versus servile leadership, 5/10:106
The unled and the untrained, 6/10:134
The difficulty of knowing what to ignore, 7/10:122
Good conversations lead to good jobs, 08/10:102
Productivity and the workplace, 09/10:134
Becoming a star at letting stars be stars, 10/10:102
How ideas get killed, 11/10:130
New ideas—trial and error, 12/10:90
FISH (Fluorescence in situ hybridization)
Molecular testing moves to Main Street, 11/10:1
From the President’s Desk
The silver lining on guidelines debate, 1/10:11
How to up the opportunity odds, 2/10:11
The transformation ecosystem, 3/10:11
A yardstick for transformation, 4/10:11
Numbers that point to our next steps, 5/10:11
Big-picture thinking and opportunity, 6/10:11
How pathology reports communicate, 7/10:11
Stepping up will mean standing out, 08/10:11
Building a fact-based case for change, 09/10:11
Our challenge to communicate clearly, 10/10:11
Where advocacy, transformation meet, 11/10:11
Rationale for the roundtable, 12/10:11
Future trends
Face value—pathologists one on one with patients, 11/10:44
When pathologists meet patients—lessons from one FNA practice, 12/10:64
Gene patents
Friend or foe? Looking at gene patents, 2/10:1
Gene patents—sizing up the surprising first step, 5/10:38
Genetics/genetic testing
3 of a kind: CF screening, 3/10:1
Talk it out—on genomics, TB, glucose, more, 6/10:5
Genomics
Pathology residents prep for personal genomics, 2/10:66
Talk it out—on genomics, TB, glucose, more, 6/10:5
Glucose/insulin/blood sugars
Cola, confection, and confusion: OGTT alternatives for gestational diabetes, 6/10:78
H1N1 virus/swine flu
Latest flu spread full of surprises, 2/10:1
Health care reform
In health care reform, labs have winning hand, 7/10:12
Human papillomavirus
New FDA approvals of HPV vaccines, 1/10:48
HPV testing—proceed, with cautions, 10/10:1
Immunodeficiency disease
Update: primary immunodeficiency disease, 7/10:1
Immunohistochemistry
Whole new world for IHC, molecular, 1/10:1
Making ER/PgR practices toe the line, 4/10:1
Infectious diseases
Trail of clues leads to infectious organisms, 12/10:1
Promise and provisos of pediatric diagnostic testing, 12/10:5
Informatics (see Automation and Information systems, software technologies)
Information systems, software technologies (see also Automation)
Smarter, smoother decision management through middleware, 2/10:26
Middleware systems, 2/10:31
If your lab’s AP system ain’t broke, just tweak it, 3/10:14
Anatomic pathology computer systems, 3/10:16
Lab-link companies focus on future, strengthen connectivity, 4/10:18
Laboratory-provider links software, 4/10:24
Ratcheting up labs’ revenue cycle management, 5/10:18
With billing systems, the proof’s in the pay, 5/10:18
Billing/accounts receivable systems, 5/10:21
Positive patient ID: where it’s at and where it’s going, 7/10:66
Positive patient identification products, 7/10:67
Blood bank companies branching out and barreling ahead, 09/10:74
Blood bank information systems, 09/10:78
Who goes where, when? Scheduling made easier, 10/10:60
LIS training: Introducing you to what you already own, 11/10:71
Laboratory information systems, 11/10:76
Instrumentation/instrument product guides
What’s new and what’s next for coagulation analyzers, 1/10:18
Coagulation analyzers product guide, 1/10:19
What’s new in point-of-care glucose analyzers, 2/10:12
Bedside glucose testing systems, 2/10:15
Laughter, less stress—labs talk up integrated analyzers, 4/10:48
The latest in POC and self-testing coag, 5/10:56
Coagulation analyzers—point of care, self-monitoring, 5/10:56
Immunoassay analyzers—what’s new and notable, 6/10:16
Automated immunoassay analyzers, 6/10:19
Adaptable chemistry analyzers taking the field, 7/10:22
Chemistry analyzers for mid- and high-volume laboratories, 7/10:23
For blood gas analyzers, larger menus and new features, 08/10:21
In vitro blood gas analyzers, 08/10:22
Lab automation—open, modular, informatics-focused, 09/10:18
Laboratory automation systems and workcells, 09/10:22
Chemistry analyzers fitting for low-volume labs, 10/10:20
Chemistry analyzers (for low-volume laboratories), 10/10:21
Automated molecular platforms, 11/10:27
Hematology analyzers: an overview of what’s new, 12/10:22
Hematology analyzers, 12/10:22
Insulin (see Glucose/insulin/blood sugars)
Iron overload
Closing the gap in transfusion-related iron overload, 5/10:1
Joint Pathology Center
New center underway as AFIP winds down, 10/10:64
Kidney disease
Honing drug dosing with standardized eGFR, 3/10:1
Lab-developed tests/homebrews
Prepping for a firmer FDA hand in regulating LDTs, 09/10:5
Lab portals
Lab-link companies focus on future, strengthen connectivity, 4/10:18
Laboratory efficiency/cost-savings measures
Thanks to a weak economy and more, efficiency is king, 4/10:5
Point-of-care testing through the lens of Lean, 4/10:62
Reeling in expense of reference lab testing, 08/10:1
Laboratory profiles
Thanks to a weak economy and more, efficiency is king, 4/10:5
Laboratory test problems/pitfalls
Common lab tests, uncommon problems, 1/10:1
Pulling back the reins on superfluous testing, 09/10:1
Lab test utilization management
Pulling back the reins on superfluous testing, 09/10:1
In coagulation, reflexive testing algorithms do the trick, 09/10:52
Lean manufacturing principles/Six Sigma (see also Laboratory efficiency/cost-savings measures)
Point-of-care testing through the lens of Lean, 4/10:62
Legal issues/actions (see also Medical mistakes)
Friend or foe? Looking at gene patents, 2/10:1
Gene patents—sizing up the surprising first step, 5/10:38
Legislation
By July 2011, a demo on direct Medicare payment, 7/10:5
In health care reform, labs have winning hand, 7/10:12
Letters
CYP2C19 genotyping for clopidogrel dosing, 6/10:14
C. difficile detection, 7/10:6
Diagnosing diabetes, 09/10:16
Specimen ID errors, 09/10:16
TC/PC arrangements and in-office labs, 10/10:11
Fair value, 12/10:11
Face value, 12/10:12
Management issues
Shape up? Ship out? Handling problem colleagues, 11/10:106
Medical mistakes (see also Legal issues/actions)
Unmasking specimen ID errors, every step of the way, 6/10:94
Medicare/Medicaid
By July 2011, a demo on direct Medicare payment, 7/10:5
Ins and outs, plus doubts, about TC/PC setups, 08/10:74
Metabolic syndrome
Coming to terms with ‘metabolic syndrome’, 2/10:1
Microbiology
Smart choice for C. diff detection—PCR, 5/10:1
Labs seeing the light on practice guidelines, 08/10:1
New AST breakpoints bolster fight against resistance, 09/10:58
Another resistance mechanism poses worldwide threat, 09/10:66
Promise and provisos of pediatric diagnostic testing, 12/10:5
Molecular diagnostics (see also Polymerase chain reaction [PCR] technology)
Whole new world for IHC, molecular, 1/10:1
Solid (tumor) reasons for molecular biomarkers, 2/10:60
Multiplex RVPs enticing labs to molecular, 4/10:1
Experts peer into molecular crystal ball, 09/10:1
Molecular testing moves to Main Street, 11/10:1
C. diff molecular testing with less time and effort, 11/10:97
Newsbytes
Free online course an education in pathology informatics, 1/10:77
Abbott to acquire Starlims Technologies, 1/10:78
Microsoft to purchase Sentillion, 1/10:78
Atlas Medical Software introduces electronic prescribing portal, 1/10:78
Fisher HealthCare to market Orchard lab information systems, 1/10:78
Nuance offering system for critical test result management, 1/10:79
Francisco Partners to buy QuadraMed, 1/10:79
Biolmagene teams with Penn, Rutgers to develop algorithms for diagnostic use, 1/10:79
Federal government debuts health care information technology blog, 1/10:79
Supercomputer tackles genetic sequencing for HIV, 2/10:89
Lawson Software to buy Healthvision Solutions, 2/10:89
Halfpenny system transfers lab results to smartphones, 2/10:90
Mediware offers interface to U.S. Biovigilance Network, 2/10:90
Bio-Key launches Saas solution for biometric ID, 2/10:90
Government sets up grants for IT training programs, 2/10:90
CAP releases updated XML version of cancer checklists, 2/10:90
LifePoint supplies clinical data tools for Web platform, 2/10:90
Can’t afford an LIS? Get a free one from Schuyler House, 3/10:82
New CDC program to track adverse blood transfusions, 3/10:84
Haemonetics to purchase Global Med Technologies, 3/10:84
Spectra Laboratories streamlines processes with McKesson LIS, 3/10:85
Consumer Electronics Show for medical consumers too, 3/10:85
Teleconference on electronic lab reporting to public health, 3/10:85
WEDI offering free online ICD-10 vendor resource directory, 3/10:86
Emdeon buys FutureVision, 3/10:86
How labs can add value to EMR adoption process, 4/10:88
Why one hospital is using an LIS in lieu of a LIMS for tissue banking, research, 4/10:89
Verizon introduces platform for sharing patient notes in a digital format, 4/10:89
New Sunquest contracts and installations, 4/10:90
At PHS/Oregon, ‘meaningful use’ is nothing new, 5/10:96
Brady Worldwide releases latest version of label-design software, 5/10:96
A parade of products and services in HIMSS vendor exhibition, 5/10:97
AssistMed introduces platform to digitize medical information, 5/10:97
Upcoming LOINC workshop and meeting, 5/10:97
Orchard Software goes live with blog, 5/10:98
New handwashing compliance system offers more than a reminder, 6/10:123
Blood center accelerates on-site donor registration process, 6/10:124
Mediware introduces software for e-learning and compliance, 6/10:124
Data Innovations offering new version of Instrument Manager, 6/10:125
Two more lab-link companies, 6/10:125
At one lab, reflex testing tipped scales when weighing LIS choices, 7/10:111
Allscripts to purchase Eclipsys, 7/10:112
Thermo Fisher Scientific offers SaaS-based LIMS, 7/10:112
Halfpenny Technologies acquires Laboratory Management Services, 7/10:112
Medicity to release platform for information exchange, 7/10:112
CAP becomes sponsor for IHE Laboratory Domain, 7/10:112
CCHIT chooses test tool from Ignis for HER certification, 7/10:113
Cove introduces new version of inventory management system, 7/10:113
A case for reporting laboratory results to EMRs in dual formats, 08/10:92
Federal government releases final rules on meaningful use, 08/10:93
Association for Pathology Informatics unveils journal, 08/10:94
Medrium to use laboratory results distribution system of RelayHealth, 08/10:94
CDC grant to support electronic exchange of laboratory data, 08/10:94
Company’s mission: deter and detect patient privacy breaches from within, 09/10:122
Investment firm purchases Aspyra, 09/10:122
Royal Philips and Dako join forces in digital pathology endeavor, 09/10:122
Ingenix and Axolotl to merge, 09/10:122
Halfpenny and HT Systems partner on biometric product, 09/10:123
HL7 standards and guides in federal meaningful use rule, 09/10:123
Haemonetics signs contract with GPO, 09/10:123
Health care informatics: the new kid on campus, 10/10:94
CSC outlines challenges to implementing meaningful use, 10/10:95
New government Web site registers medical volunteers, 10/10:96
Sunquest upgrades Collection Manager software, 10/10:96
SCC releases enhanced version of SoftBank II, 10/10:96
Assessing the security practices of third-party billing firms, 11/10:116
Sunquest releases diagnostic business intelligence solution, 11/10:117
Elekta debuts latest version of AP system, 11/10:117
The conundrum of shortcut keys for the Web-based LIS, 11/10:118
Cerner expands revenue cycle management business, 11:10:119
Hyland Software acquires Computer Systems Company, 11/10:119
Ingenix to purchase A-Life Medical, 11/10:119
Siemens shifting from train-the-trainer to train-each-employee approach, 12/10:83
Interface workarounds offer fixes for common issues, 12/10:83
Acquisitions in the health care information technology market, 12/10:84
CLSI releases StatisPro method-evaluation software, 12/10:84
ONC Web site lists products cleared for meaningful use, 12/10:84
Obituary
Daniel L. Seckinger Jr., MD, 1/10:5
Pathologist profiles
Lab turns field hospital into one that’s more real, 5/10:74
When pathologists meet patients—lessons from one FNA practice, 12/10:64
Pathologists abroad (see also Volunteer/charity work)
Women in Guyana, others, counting on labs in U.S., 4/10:80
Patient consults
Face value—pathologists one on one with patients, 11/10:44
Patient ID systems/patient safety
Hammering away at patient ID error, 4/10:1
Positive patient ID: where it’s at and where it’s going, 7/10:66
Positive patient identification products, 7/10:67
Payment issues
Ins and out, plus doubts, and about TC/PC setups, 08/10:74
Promise and provisos of pediatric diagnostic testing, 12/10:5
Pediatric patients
Promise and provisos of pediatric diagnostic testing, 12/10:5
Personalized medicine/testing
Personal learning about personalized medicine, 10/10:1
Pharmaceuticals
GRAVITAS findings part of Plavix puzzle, 12/10:1
Physician fee schedule
Sizing up the 2010 physician fee schedule final rule, 2/10:43
Point-of-care testing
Eye the basics, not baubles, for point-of-care testing, 1/10:60
Packing POC dossier into new online tool kit, 08/10:5
Room to grow—warfarin self-testing still lags, 08/10:60
Polymerase chain reaction (PCR) technology
Smart choice for C. diff detection—PCR, 5/10:1
Practice guidelines
Labs seeing the light on practice guidelines, 08/10:1
Proficiency testing
Seeking partners, samples for alternative PT, 1/10:7
Progesterone receptors (see Estrogen receptors/progesterone receptors)
Q&A
I am finding apparent conflicts with required laboratory tests for stroke and what I think are best lab practices. Please advise. (Remmel, McKane, Laskowitz, Goldstein), 1/10:76
Is it medically feasible for a WBC count to go from 69.0 to less than 10.0 in about six hours? (Galagan), 2/10:86
We have been having QC problems with our fibrinogen level N. Consequently, my supervisor wants to run QC for fibrinogen 20 times. Are there other suggestions or guidelines for such a problem? (Ledford-Kraemer), 2/10:87
When there is a low platelet count, can we use platelet estimate from blood smear as an alternative method, or is it necessary to use the Unopette method? (Galagan), 2/10:88
Is occult malignancy likely to lead to hypercoagulability? (McKane), 2/10:89
What is the suggested range for “random” blood glucose measurements? (Sacks), 3/10:81
Necessity of testing lipase and amylase when you can test for p-amylase to aid in the diagnosis of pancreatitis, (Lew, Lewandrowski), 3/10:81
The diurnal biological coefficients of the MCH and MCHC (Galagan), 4/10:90
Link between Schistosoma haematobium and proteinuria (Arcenas), 4/10:90
The critical absolute neutrophil count for pediatric and adult patients (Perry), 4/10:92
Recommendations for contacting ordering caregivers for outpatients after a clinic closes (Hernandez), 5/10:94
Testing lung specimens obtained from bronchial wash, bronchoalveolar lavage, and bronchial brush specimens (Arcenas), 5/10:94
Should we report smudge cells? (Perry), 6/10:122
Are there any articles that indicate that NT-proBNP is useful? (Januzzi), 6/10:122
Is there a place for ectocervical brushings in gynecologic cytology? (Trench), 7/10:114
When a patient’s pretransfusion temperature is less than 98.6°F but then rises above 98.6°F, when is it considered a febrile transfusion reaction? (Shaz), 7/10:114
Does chromosomal analysis contribute in decisions for therapy, staging, or prognosis for patients with myeloma? (Ansari-Lari), 7/10:114
What is the correct way to handle polycythemic patients who have high hermatocrits? (George), 08/10:90
How useful are immature granulocytes in an automated differential cell count? (Werner), 08/10:92
If a patient sustains a subarachnoid hemorrhage from a ruptured cerebral aneurysm, how long will it take before the appearance of hemosiderin pigment? (DeMasters), 09/10:124
What is the significance of an isolated finding of loss of MLH1 staining, and should the patient’s children have genetic counseling? (Plesec), 09/10:124
How reliable are GC Gram stains for female patients? Are there recommendations or guidelines for accepting these orders? (Wojewoda), 10/10:92
What are the etiology, diagnostic symptomatology, and therapeutic options for the rare lung anomaly Langerhans cell histiocytosis? (Suster), 10/10:92
Is the use of ammonia capsules (inhalers) no longer recommended for syncope/fainting patients? (Rosser), 11/10:120
What is meant by waived or nonwaived testing? (Nichols, Ledden), 11/10:120
Calculating the estimated glomerular filtration rate, or eGFR? (Miller), 12/10:82
Value of PCR in identifying the causative organism in prostatitis (Wojewoda), 12/10:82
Quality control/quality improvement
Critical value repeats—redundancy, necessity? 12/10:1
Q-Probes and test management
Unmasking specimen ID errors, every step of the way, 6/10:94
Critical value repeats—redundancy, necessity? 12/10:1
Radiology (see Co-mingling of radiology and pathology)
Reference lab testing services
Reeling in expense of reference lab testing, 08/10:1
Respiratory viruses/treatments
Multiplex RVPs enticing labs to molecular, 4/10:1
Safety (See also Patient ID systems/patient safety)
Hammering away at patient ID error, 4/10:1
Screening tests
A1c: added oomph to diagnosing diabetes, 7/10:1
Cytology screening limits, by the numbers, 10/10:1
Scuttling surrogate testing of platelets, 11/10:1
Self-testing (see also Point-of-care testing)
Room to grow—warfarin self-testing still lags, 08/10:60
Sepsis
No longer sunk by sepsis, 11/10:1
Shorts on Standards
Information technology in cellular therapy, 6/10:78
Coagulation quality assessment review, 7/10:90
Clinical genetics meeting update, 09/10:126
Sickle cell anemia
Closing the gap in transfusion-related iron overload, 5/10:1
Social media
Social media in labs—hook, line, and sinker, 10/10:1
Specimen collection
Unmasking specimen ID errors, every step of the way, 6/10:94
System review series (see Information systems, software technologies)
Test development
Multiplex RVPs enticing labs to molecular, 4/10:1
Test turnaround time/time management
Bold move by one lab drops troponin TAT, 6/10:1
Transfusions (see Blood banking/transfusions)
Troponin
Keeping in step with the perfecting of troponin, 1/10:1
Bold move by one lab drops troponin TAT, 6/10:1
Urinalysis
Atlas blazes color path across full spectrum of urinalysis, 11/10:5
Vitamins
Boning up on vitamin D testing advances, 6/10:1
Volunteer/charity work (see also Pathologists abroad)
Women in Guyana, others, counting on labs in U.S., 4/10:80
Lab turns field hospital into one that’s more real, 5/10:74
|
|
|
Related Links